Morgan Stanley upped its price objective and gave a buy rating, while Jefferies reiterated an underperform rating for Palantir Technologies.

The entities involved

• Palantir Technologies →

  American software and services company, specializing in data analysis

  • Palantir's contracts are reported by NPR, while Jon Tester advises the company and Ron Wyden demands answers regarding mass surveillance.07:16
  • Zeta Interactive and Palantir Technologies announced a partnership for AI infrastructure development.06:34
• Morgan Stanley →

  U.S. investment bank

  • Citigroup upgraded Next plc to a buy rating, while Santander and Morgan Stanley also issued rating updates on the company.08:04
  • IPO trading achieves market cap parity for a company, raising funds for a new AI empire, involving market leaders like Nvidia, Amazon, and Microsoft.Tue 11:27
• Jefferies Financial Group →

  American financial services company

  • Jefferies Financial Group and TD Cowen initiated coverage and set buy ratings for Electra Therapeutics, with a director also purchasing shares.03:52
  • Gap Inc. filed with the SEC regarding institutional investment activity, and Jefferies downgraded its stock rating and target price.Tue 11:56

Related events

• Jefferies Financial Group reiterated a buy rating on Constellation Software stock.Fri 17:54
• Raymond James Financial reaffirmed a strong-buy rating and Morgan Stanley set a $25.00 price objective for VIR Biotechnology.Oct 10
• Morgan Stanley and Jefferies Financial Group adjusted price targets and ratings for Lincoln National Corporation.Nov 4
• Multiple financial firms, including Jefferies, Bank of America, and Raymond James, issued price objective and rating updates on October 23, 2026.Oct 24
• Financial firms, including Jefferies, RBC, and Wells Fargo, issued rating and price objective updates for Biogen.Oct 23